Symbol Lookup

Saturday May 28, 2016 3:36 PM ET. Data delayed 15 minutes.
0.21 (1.89%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
European ADRs Marginally Higher as Pharma Stocks See Mixed Fortunes
10:56AM ET on Monday May 02, 2016 by MT Newswires
10:56 AM EDT, 05/02/2016 (MT Newswires) -- American depository receipts of European stocks were 0.2% higher at 124.81 on the Bank of New York Mellon Europe ADR Index on Monday morning. Gainers in Continental Europe were led by Flamel Technologie...
European ADRs Edge Lower as Banks Head South
10:35AM ET on Friday Apr 29, 2016 by MT Newswires
10:35 AM EDT, 04/29/2016 (MT Newswires) -- American depository receipts of European stocks were trading 0.4% lower at 124.74 on the Bank of New York Mellon Europe ADR Index on Friday morning. Decliners in Continental Europe were led by French he...

Company Information

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.


HeadquartersIDA Business Park
BRAY, Ireland 18


Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$271.9MBeta0.93
Revenue (TTM)$100.2MEPS$0.77
Shares Out.24.0MBook Value$8.93
Dividend Yield1.94%P/E14.8x
Annual Dividend Rate0.22 USDPrice/Sales (TTM)2.7
Ex-Div Date6/5/15P/Cash Flow (TTM)--
Pay Date7/1/15Operating Margin13.42%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample